(2R)-3-methyl-2-[[9-propan-2-yl-6-[(4-pyridin-3-ylphenyl)methylamino]purin-2-yl]amino]butan-1-ol
C25H31N7O — CID 25053057
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2R)-3-methyl-2-[[9-propan-2-yl-6-[(4-pyridin-3-ylphenyl)methylamino]purin-2-yl]amino]butan-1-ol
(2R)-3-methyl-2-[[9-propan-2-yl-6-[(4-pyridin-3-ylphenyl)methylamino]purin-2-yl]amino]butan-1-ol (PubChem CID 25053057) has the molecular formula C25H31N7O and a molecular weight of 445.57 g/mol. Its IUPAC name is (2R)-3-methyl-2-[[9-propan-2-yl-6-[(4-pyridin-3-ylphenyl)methylamino]purin-2-yl]amino]butan-1-ol.
Molecular Properties
| Compound Name | (2R)-3-methyl-2-[[9-propan-2-yl-6-[(4-pyridin-3-ylphenyl)methylamino]purin-2-yl]amino]butan-1-ol |
|---|---|
| PubChem CID | 25053057 |
| Molecular Formula | C25H31N7O |
| Molecular Weight | 445.57 g/mol |
| Exact Mass | 445.26 |
| IUPAC Name | (2R)-3-methyl-2-[[9-propan-2-yl-6-[(4-pyridin-3-ylphenyl)methylamino]purin-2-yl]amino]butan-1-ol |
| SMILES | CC(C)[C@H](CO)Nc1nc(NCc2ccc(-c3cccnc3)cc2)c2ncn(C(C)C)c2n1 |
| InChI | InChI=1S/C25H31N7O/c1-16(2)21(14-33)29-25-30-23(22-24(31-25)32(15-28-22)17(3)4)27-12-18-7-9-19(10-8-18)20-6-5-11-26-13-20/h5-11,13,15-17,21,33H,12,14H2,1-4H3,(H2,27,29,30,31)/t21-/m0/s1 |
| InChIKey | IYXZIWWZTOYESX-NRFANRHFSA-N |
| XLogP | 4.51 |
| TPSA | 100.78 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 445.57 |
| LogP ≤ 5 | 4.51 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 25053057 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.